Subscribe to RSS
DOI: 10.1055/s-0038-1629631
Der Einfluß von Ca-Diethylentriaminpentaacetat auf das Bioverhalten tumoraffiner Metallkomplexe
The effect of Ca-Diethylenetriamine Pentaacetate on the Biological Behaviour of Tumour-Affine Metal ComplexesPublication History
Eingegangen:
05 April 1992
Publication Date:
04 February 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00034924/199206/lookinside/thumbnails/10-1055-s-0038-1629631_de-1.jpg)
Zusammenfassung
Das Komplexon CaDTPA wurde tumortragenden Mäusen in Konzentrationen von 0.05, 0.1, 0.3 und 0.6 mol/l 30 min nach Applikation von 169Yb-Zitrat injiziert. 100 µl einer 0.3 M CaDTPA-Lösung wurden zu unterschiedlichen Zeitpunkten (gleichzeitig, 2, 5, 10, 20, 30, 40 und 50 min, 1, 1.25, 1.5, 2.5 und 10 h) nach 169Yb-Zitrat-lnjektion injiziert. Die Tiere wurden 24 h nach Radionuklidgabe getötet. Ein starker Radioaktivitätsabfall, nicht nur in Blut, Leber, Milz, Muskel und Knochen, sondern auch im Tumor konnte 24h p.i. dann beobachtet werden, wenn CaDTPA innerhalb von 2 h nach Ytterbiuminjektion gegeben wurde. Danach wurde durch DTPA keine Radioaktivitätsänderung mehr erreicht. Eine Zeitphase, in welcher Yb von den Geweben eliminierbar war (Zeitintervalle <2 h), konnte von einer Zeitphase abgegrenzt werden, in welcher Yb nicht mehr für DTPA erreichbar war (Zeitintervalle >5 h). Das zeigt, daß die Yb-Inkorporation in die Zellen nach 5 h abgeschlossen ist und die Metalle intrazellulär, wahrscheinlich in den Lysosomen, gebunden sind. Verbesserungen des szintigraphischen Tumornachweises können von der Verwendung von Komplexonen nicht erwartet werden.
Summary
The complexon CaDTPA was injected into tumour-bearing mice in concentrations of 0.05, 0.1, 0.3, and 0.6 mole/l (pH:6) 30 min after the 169Yb-injection. 100 µl of a 0.3 M CaDTPA solution were injected at different time points (simultaneously, 2, 5, 10, 20, 30, 40 and 50 min, 1, 1.25, 1.5, 2.5 and 10 h) after 169Yb-citrate injection. The animals were killed 24 h after radionuclide administration. A strong radioactivity decrease was observable 24 h p.i. not only in blood, liver, spleen, muscle and bone but also in the tumour if CaDTPA was administered within the first 2 h after ytterbium injection. Thereafter no change in radioactivity could be achieved by DTPA. A time phase in which the Yb could be eliminated from the tissues by means of DTPA (time intervals <2 h) was distinguishable from a time phase in which it was not attainable for DTPA (time intervals >5 h). This indicates that the incorporation of Yb into the cells is completed after 5 h and that the metals are intracellularly bound, probably to the lysosomes. Improvements of the scintigraphic tumour detection cannot be expected from the use of complexones.
-
Literatur
- 1 Ando A, Hisada K, Hiraki T, Ando I, Sanada S. The mechanism of the tumor affinity of 169Yb, 67Ga and 111In in the short term after i.v. injection and the form of chemical bond in the tumor tissue. Radioisotopes (Tokyo) 1974; 23: 161-6.
- 2 Ando A, Ando I, Hiraki T, Takeshita M, Hisada K. Mechanism of tumor and liver concentration of 111In and 169Yb. Eur J Nucl Med 1982; 07: 298-303.
- 3 Ando A, Ando I, Hiraki T, Takeshita M, Hisada K. Mechanism of tumor and liver concentration of 67Ga: 67Ga binding substances in tumor tissues and liver. Jnt J Nucl Med Biol 1983; 10: 1-9.
- 4 Ando A, Ando I, Sakamoto K. et al. Affinity of 169Yb-citrate for tumor and liver tissue. Eur J Nucl Med 1983; 08: 440-6.
- 5 Ando A, Ando I, Sanada S, Hiraki T, Hisada K. Tumor and liver uptake models of 67Ga-citrate. Eur J Nucl Med 1985; 10: 262-8.
- 6 Ando A, Ando I, Hiraki T, Hisada K. Relation between the location of elements in the periodic table and various organ-uptake rates. Nucl Med Biol 1989; 16: 57-80.
- 7 Anghileri LJ. Role of tumor phospholipids in the accumulation of 67Ga-citrate. J Nucl Biol Med 1972; 11: 21-4.
- 8 Anghileri LJ. Cell membrane ionic permeability, calcium ions, mitochondria and carcinogenesis. Arch Geschw-forsch 1978; 48: 497-504.
- 9 Blank ML, Cress A, Byrd BL. Liposomal encapsulated Zn-DTPA for removing intracellular 169Yb. Health Phys 1980; 39: 913-20.
- 10 Catsch A, Wedelstedt E. Vergleichende Untersuchungen über die Toxizität der Ca-und Zn(II)-Chelate der Dieäthylentriaminpentaessigsäure. Experienta 1965; 21: 210-1.
- 11 Catsch A, Harmuth-Hoene AE. New developments in metal antidotal properties of chelating agents. Biochem Pharmacol 1975; 24: 1557-62.
- 12 Harrison JD, David AJ. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination. Radiat Res 1979; 77: 534-46.
- 13 Hoffer PB, Samuel A, Bushberg DJ, Thakur M. Desferioxamine mesylate (Desferal): A contrastenhancing agent for gallium-67 imaging. Radiology 1979; 131: 775-9.
- 14 Larson SM, Rasey JS, Grunbaum Z, Allen DR. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 sarcoma (BALB/c mice). Radiology 1979; 130: 241-4.
- 15 Markley JF, Rosenthal MW, Lindenbaum A. Distribution and removal of monomeric and polymeric plutonium in rats and mice. Intern J Radiat Biol 1964; 08: 271-8.
- 16 Nenot JC, Morin M, Lafuma J. Etude metabolique et therapeutique des contaminations respiratoires par certains actinides en solution. Health Phys 1971; 20: 167-77.
- 17 Oster ZH. The effect of desferoxamine-mesylate (Desferal) on the biodistribution of gallium-67 citrate. J Nucl Med 1978; 19: 732.
- 18 Rockstroh K. Verfahren zur Herstellung von 169Yb-Zitrat. Jahresbericht des ZfK Rossendorf ZfK-312. Münze R. Hrsg: 1976: 71-5.
- 19 Schomäcker K, Franke WG, Henke E. et al. The influence of isotopic and nonisotopic carriers on the biodistribution and biokinetics of M3 + -citrate-complexes. Eur J Nucl Med 1986; 11: 345-9.
- 20 Schomäcker K, Franke WG, Mocker D, Münze R, Beyer GJ. Zur Radiopharmakologie von M-Li-gand-Komplexen. Radiobiol Radiother 1987; 28: 835-9.
- 21 Schomäcker K, Mocker D, Münze R, Beyer GJ. Stabilities of lanthanide-protein complexes. Appl Radiat lsot 1988; 39: 261-4.
- 22 Seidel A. A multivariate analysis of Ca-DTPA effectiveness in removing Am-241 from the rat. Z Naturforsch 1973; 28c: 316-8.
- 23 Sephton RG, Harris AW. Gallium-67 nitrate uptake by cultured tumor cells stimulated by serum transferrin. J Natl Cancer Inst 1974; 54: 1263-6.
- 24 Sephton RG, Hodgson GS, De Abrew S, Harris AW. Ga-67 and Fe-59 distributions in mice. J Nucl Med 1978; 19: 930-5.
- 25 Sephton RG. Relationships between the metabolism of 67Ga and iron. Int J Nucl Med Biol 1981; 08: 323-31.
- 26 Smith VH, Ballou JE, Lund J. Aspects of inhaled DTPA toxicity in the rat, hamster and beagle dog and treatment effectiveness for excorporation of plutonium from the rat. In: Diagnosis and treatment of incorporated radionuclides. Vienna: IAEA; 1976: 517-30.
- 27 Stather JW, Smith H, James AC, Rodwell P. The experimental use of aerosol and liposomal forms of Ga-DTPA as a treatment for plutonium contamination. In: Diagnosis and treatment of incorporated radionuclides. Vienna: IAEA; 1976: 387-400.